Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions ##### Up next ![GEEKOM celebrates its 21st year in the PC industry.](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2024/06/image_5019393_21475314.jpg?resize=200%2C110&ssl=1 "GEEKOM celebrates its 21st year in the PC industry.") [](https://thailandbusinessnews.net/press-release/geekom-celebrates-its-21st-year-in-the-pc-industry-2/) ###### [GEEKOM celebrates its 21st year in the PC industry.](https://thailandbusinessnews.net/press-release/geekom-celebrates-its-21st-year-in-the-pc-industry-2/) Published on 12 June 2024 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) SAN FRANCISCO and SUZHOU, China, June 12, 2024 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that it will present multiple clinical study results of mazdutide at the American Diabetes Association’s® (ADA) 84th Scientific Sessions in Orlando from June 21 -24. Innovent will share the results from the first phase 3 study of mazdutide in Chinese adults with obesity and overweight (GLORY-1), an exploratory analysis of GLORY-1 on liver steatosis, as well as a Phase 2 study of mazdutide 9 mg in adults with obesity during one oral presentation and two posters. Details are listed below: Title: Efficacy and Safety of Mazdutide in Chinese Participants with Overweight or Obesity (GLORY-1) Abstract #: 1856-LBPresentation Form: Oral（ePoster Theater）Time: 2024 June 23, 13: 30 PM – 13: 40 PM（EST）Presenter: Dr. Linong Ji, Peking University People’s Hospital Title: Improvement of Liver Steatosis by Mazdutide in Chinese Participants with Overweight or Obesity—An Exploratory Analysis of GLORY-1 Abstract #: 1857-LBPresentation Form: Poster presentation Title: A Phase 2 Study of Mazdutide 9 mg in Chinese Adults with BMI of 30 kg/m2 or more Abstract #: 1866-LBPresentation Form：Poster presentation Dr. Lei Qian, Vice President of Clinical Development of Innovent, stated, " We are excited to announce the results of GLORY-1 at ADA scientific sessions. Mazdutide is the first GLP-1R/GCGR dual agonist that succeeded in a Phase 3 registration study for people with overweight/obesity. Meanwhile, the strong results of a Phase 2 study of mazdutide 9mg in Chinese adults with moderate-to-severe obesity will also be released at ADA, and the corresponding Phase 3 GLORY-2 is currently ongoing. Mazdutide is anticipated to provide an individualized, effective and safe weight management option for people with overweight or obesity at different severities. " About Mazdutide (IBI362) Innovent entered into an exclusive license agreement with Eli Lilly and Company (Lilly) for the development and potential commercialization of OXM3 (also known as mazdutide), a GLP-1R and GCGR dual agonist, in China. As a mammalian oxyntomodulin (OXM) analogue, with the effects of GLP-1 receptor agonists to promote insulin secretion, lowering blood glucose and reducing body weight, mazdutide may also increase energy expenditure and improve hepatic fat metabolism through the activation of glucagon receptor. Mazdutide has demonstrated robust weight loss and glucose-lowering effects in clinical studies as well as improvements in multiple cardio-metabolic indicators including reducing waist circumference, blood lipids, blood pressure, blood uric acid, liver enzymes, liver fat content and improved insulin sensitivity. Currently, five Phase 3 studies of mazdutide in Chinese adults with overweight or obesity (GLORY-1 and GLORY-2) and type 2 diabetic (DREAMS-1, DREAMS-2 and DREAMS-3) subjects are underway, where GLORY-1 and DREAMS-2 studies have met their primary endpoints. In February 2024, the first NDA of mazdutide was accepted by the CDE of the NMPA of China for chronic weight management in adults with obesity or overweight. About Innovent Innovent is a leading biopharmaceutical company founded in 2011 with the mission to provide high-quality biologics that are affordable to all. The company discovers, develops, manufactures and commercializes innovative medicines that treat some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has 10 products in the market, 4 new drug applications under the NMPA review, 4 assets in Phase III or pivotal clinical trials and 18 more molecules in early clinical stage. Innovent partners with over 30 global healthcare leaders, including Eli Lilly, Roche, Sanofi, Adimab, Incyte and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit [www.innoventbio.com](https://www.innoventbio.com/), or follow Innovent on Facebook and LinkedIn. Statement: Innovent does not recommend the use of any unapproved drug (s)/indication (s). Forward-looking statement This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Innovent Biologics ("Innovent"), are intended to identify certain of such forward-looking statements. The Company does not intend to update these forward-looking statements regularly. These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of the Company with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond the Company’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, the Company’s competitive environment and political, economic, legal and social conditions. The Company, the Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or is otherwise inaccurate. [Source link ](https://www.prnasia.com/story/archive/4436702_AE36702_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/km-malta-airlines-the-maltese-islands-new-national-carrier-implements-cellpoint-digitals-payment-orchestration-solution/) ## KM Malta Airlines, the Maltese Islands' New National Carrier, Implements CellPoint Digital's Payment Orchestration Solution The partnership will enable KM Malta Airlines to provide passengers with a… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - September 23, 2024 [](https://thailandbusinessnews.net/press-release/neberon-heated-gloves-your-best-winter-companion-for-christmas/) ![Neberon Heated Gloves: Your Best Winter Companion for Christmas](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/12/1920.jpg?resize=260%2C140&ssl=1 "Neberon Heated Gloves: Your Best Winter Companion for Christmas") - [Press Release](https://thailandbusinessnews.net/category/press-release/) - [Tech](https://thailandbusinessnews.net/category/tech/) ## Neberon Heated Gloves: Your Best Winter Companion for Christmas Unveiling the Perfect Blend of Warmth and Style for Skiing Season and… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - December 8, 2023 [](https://thailandbusinessnews.net/press-release/mabwell-passes-on-site-gmp-inspection-by-regulatory-authority-of-pic-s-member-country-jordan-for-the-first-time/) ## Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time SHANGHAI, April 21, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - April 21, 2026 ##### Most Read - [![DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") [DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") - [![Department of International Trade Promotion Organizes ELMA 2026 Award Presentation Ceremony Honoring Thai Logistics Businesses and Showcasing Excellence in Logistics Management](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/department-of-international-trade-promotion-organizes-elma-2026-award-presentation-ceremony-honoring-thai-logistics-businesses-and-showcasing-excellence-in-logistics-management/ "Department of International Trade Promotion Organizes ELMA 2026 Award Presentation Ceremony Honoring Thai Logistics Businesses and Showcasing Excellence in Logistics Management") [Department of International Trade Promotion Organizes ELMA 2026 Award Presentation Ceremony Honoring Thai Logistics Businesses and Showcasing Excellence in Logistics Management](https://thailandbusinessnews.net/press-release/department-of-international-trade-promotion-organizes-elma-2026-award-presentation-ceremony-honoring-thai-logistics-businesses-and-showcasing-excellence-in-logistics-management/ "Department of International Trade Promotion Organizes ELMA 2026 Award Presentation Ceremony Honoring Thai Logistics Businesses and Showcasing Excellence in Logistics Management") - [![yomo Secures Initial Banking Licence, Ready to Lead Egypt's Digital Banking Evolution](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/yomo-secures-initial-banking-licence-ready-to-lead-egypts-digital-banking-evolution/ "yomo Secures Initial Banking Licence, Ready to Lead Egypt's Digital Banking Evolution") [yomo Secures Initial Banking Licence, Ready to Lead Egypt's Digital Banking Evolution](https://thailandbusinessnews.net/press-release/yomo-secures-initial-banking-licence-ready-to-lead-egypts-digital-banking-evolution/ "yomo Secures Initial Banking Licence, Ready to Lead Egypt's Digital Banking Evolution") - [![M SOCIAL COLLECTIVE ARRIVES IN NEW YORK FOR A TWO-DAY CELEBRATION DURING US OPEN WEEK](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/m-social-collective-arrives-in-new-york-for-a-two-day-celebration-during-us-open-week/ "M SOCIAL COLLECTIVE ARRIVES IN NEW YORK FOR A TWO-DAY CELEBRATION DURING US OPEN WEEK") [M SOCIAL COLLECTIVE ARRIVES IN NEW YORK FOR A TWO-DAY CELEBRATION DURING US OPEN WEEK](https://thailandbusinessnews.net/press-release/m-social-collective-arrives-in-new-york-for-a-two-day-celebration-during-us-open-week/ "M SOCIAL COLLECTIVE ARRIVES IN NEW YORK FOR A TWO-DAY CELEBRATION DURING US OPEN WEEK") - [![CES Asia Unveiled Seoul Heads to KES on the Road to CES 2027](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/ces-asia-unveiled-seoul-heads-to-kes-on-the-road-to-ces-2027/ "CES Asia Unveiled Seoul Heads to KES on the Road to CES 2027") [CES Asia Unveiled Seoul Heads to KES on the Road to CES 2027](https://thailandbusinessnews.net/press-release/ces-asia-unveiled-seoul-heads-to-kes-on-the-road-to-ces-2027/ "CES Asia Unveiled Seoul Heads to KES on the Road to CES 2027") - [![GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") [GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/from-tokyo-to-berlin-vmfi-is-transforming-the-multilingual-communication-landscape/) ![From Tokyo to Berlin, VMFi is Transforming the Multilingual Communication Landscape.](https://i0.wp.com/mmx.prnasia.com/media/MS1970349/20260816203617EDT_image_1.jpg?resize=260%2C140&ssl=1 "From Tokyo to Berlin, VMFi is Transforming the Multilingual Communication Landscape.") ## From Tokyo to Berlin, VMFi is Transforming the Multilingual Communication Landscape. BERLIN and TOKYO, Aug. 21, 2026 /PRNewswire/ — As the world gathers… [](https://thailandbusinessnews.net/press-release/cohesity-expands-aspire-global-partner-program-with-new-specializations/) ## Cohesity Expands Aspire Global Partner Program with New Specializations Updated program broadens earning opportunities, simplifies requirements, and rewards… [](https://thailandbusinessnews.net/press-release/coway-honored-at-idea-design-awards-2026-secures-international-design-grand-slam/) ![Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'](https://i0.wp.com/mmx.prnasia.com/media/MS1972904/20260820024722EDT_image_1.jpg?resize=260%2C140&ssl=1 "Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'") ## Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam' Coway marks its 17th consecutive IDEA recognition, thus completing its sweep of… [](https://thailandbusinessnews.net/press-release/coway-honored-at-idea-design-awards-2026-secures-international-design-grand-slam-2/) ![Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'](https://i0.wp.com/mmx.prnasia.com/media/MS1972904/20260820024722EDT_image_1.jpg?resize=260%2C140&ssl=1 "Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'") ## Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam' Coway marks its 17th consecutive IDEA recognition, thus completing its sweep of…